|
1
|
Xia D, Shen K, Zhong W and Pan H:
Administration of minocycline ameliorates damage in a renal
ischemia/reperfusion injury model. Clin Invest Med. 34:E55–E63.
2011.PubMed/NCBI
|
|
2
|
Li YW, Zhang Y, Zhang L, Li X, Yu JB,
Zhang HT, Tan BB, Jiang LH, Wang YX, Liang Y, et al: Protective
effect of tea polyphenols on renal ischemia/reperfusion injury via
suppressing the activation of TLR4/NF–κB p65 signal pathway. Gene.
542:46–51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salvadori M, Rosso G and Bertoni E: Update
on ischemia–reperfusion injury in kidney transplantation:
Pathogenesis and treatment. World J Transplant. 5:52–67.
2015.PubMed/NCBI
|
|
4
|
Kiliç K, Hanci V, Selek S, Sözmen M, Kiliç
N, Citil M, Yurtlu DA and Yurtlu BS: The effects of dexmedetomidine
on mesenteric arterial occlusion–associated gut ischemia and
reperfusion–induced gut and kidney injury in rabbits. J Surg Res.
178:223–232. 2012. View Article : Google Scholar
|
|
5
|
Cong G, Cui L, Zang M and Hao L:
Attenuation of renal ischemia/reperfusion injury by a
polysaccharide from the roots of Dipsacus asperoides. Int J Biol
Macromol. 56:14–19. 2013. View Article : Google Scholar
|
|
6
|
Wang F, Yu G, Liu SY, Li JB, Wang JF, Bo
LL, Qian LR, Sun XJ and Deng XM: Hydrogen–rich saline protects
against renal ischemia/reperfusion injury in rats. J Surg Res.
167:e339–e344. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He X, Xu X, Fan M, Chen X, Sun X, Luo G,
Chen L, Mu Q, Feng Y, Mao Q and Chao Z: Preconditioning with
hyperbaric oxygen induces tolerance against renal
ischemia/reperfusion injury via increased expression of heme
oxygenase–1. J Surg Res. 170:e271–e277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiao X, Li RS, Li H, Zhu GZ, Huang XG,
Shao S and Bai B: Intermedin protects against renal
ischemia/reperfusion injury by inhibition of soxidative stress. Am
J Physiol Renal Physiol. 304:F112–F119. 2013. View Article : Google Scholar
|
|
9
|
Fisher JW: Erythropoietin: Physiology and
pharmacology update. Exp Biol Med (Maywood). 228:1–14. 2003.
|
|
10
|
Lippi G, Franchini M and Banfi G:
Biochemistry and physiology of anabolic androgenic steroids doping.
Mini Rev Med Chem. 11:362–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dimitrijevic ZM, Cvetkovic TP, Djordjevic
VM, Pavlovic DD, Stefanovic NZ, Stojanovic IR, Paunovic GJ and
Velickovic–Radovanovic RM: How the duration period of
erythropoietin treatment influences the oxidative status of
hemodialysis patients. Int J Med Sci. 9:808–815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nairz M, Sonnweber T, Schroll A, Theurl I
and Weiss G: The pleiotropic effects of erythropoietin in infection
and inflammation. Microbes Infect. 14:238–246. 2012. View Article : Google Scholar :
|
|
13
|
Stoyanoff TR, Todaro JS, Aguirre MV,
Zimmermann MC and Brandan NC: Amelioration of
lipopolysaccharide–induced acute kidney injury by erythropoietin:
Involvement of mitochondria–regulated apoptosis. Toxicology.
318:13–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen S, Li J, Peng H, Zhou J and Fang H:
Administration of erythropoietin exerts protective effects against
glucocorticoid–induced osteonecrosis of the femoral head in rats.
Int J Mol Med. 33:840–848. 2014.PubMed/NCBI
|
|
15
|
Pellegrini L, Bennis Y, Velly L,
Grandvuillemin I, Pisano P, Bruder N and Guillet B: Erythropoietin
protects newborn rat against sevoflurane–induced neurotoxicity.
Paediatr Anaesth. 24:749–759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gul M, Cömert M, Çakmak GK, Kertis G,
Ugurbas E and Oner MO: Effect of erythropoietin on liver
regeneration in an experimental model of partial hepatectomy. Int J
Surg. 11:59–63. 2013. View Article : Google Scholar
|
|
17
|
Yu Y, Shiou SR, Guo Y, Lu L, Westerhoff M,
Sun J, Petrof EO and Claud EC: Erythropoietin protects epithelial
cells from excessive autophagy and apoptosis in experimental
neonatal necrotizing enterocolitis. PLoS One. 8:e696202013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Zou YR, Zhong X, Deng HD, Pu L,
Peng K and Wang L: Erythropoietin pretreatment ameliorates renal
ischaemia–reperfusion injury by activating PI3K/Akt signalling.
Nephrology (Carlton). 20:266–272. 2015. View Article : Google Scholar
|
|
19
|
Kwon MS, Kim MH, Kim SH, Park KD, Yoo SH,
Oh IU, Pak S and Seo YJ: Erythropoietin exerts cell protective
effect by activating PI3K/Akt and MAPK pathways in C6 Cells. Neurol
Res. 36:215–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XJ, Zhang GX, Sun N, Sun Y, Yang LZ and
Du YJ: Protective effects of erythropoietin on endotoxin–related
organ injury in rats. J Huazhong Univ Sci Technolog Med Sci.
33:680–686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao L, Lu P, Li Y, Yang L, Feng H, Huang
Y, Zhang D, Chen J and Zhu D: Osthole relaxes pulmonary arteries
through endothelial phosphatidylinositol 3–kinase/Akt–eNOS–NO
signaling pathway in rats. Eur J Pharmacol. 699:23–32. 2013.
View Article : Google Scholar
|
|
22
|
Ošt'ádalová I: Biological effects of
selenium compounds with a particular attention to the ontogenetic
development. Physiol Res. 61(Suppl 1): S19–S34. 2012.
|
|
23
|
Guo F, Monsefi N, Moritz A and
Beiras–Fernandez A: Selenium and cardiovascular surgery: An
overview. Curr Drug Saf. 7:321–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Turan B, Saini HK, Zhang M, Prajapati D,
Elimban V and Dhalla NS: Selenium improves cardiac function by
attenuating the activation of NF–kappaB due to ischemia/reperfusion
injury. Antioxid Redox Signal. 7:1388–1397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karaman S, Mansuroğlu B, Kizilbey K,
Derman S and Hazar AB: Selenium status in blood, urine, and hair
samples of newly diagnosed pediatric cancer patients. Turk J Med
Sci. 45:329–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi XW, Guo X, Ren FL, Li J and Wu XM: The
effect of short tandem repeat loci and low selenium levels on
endemic osteoarthritis in China. J Bone Joint Surg Am. 92:72–80.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mehta SL, Kumari S, Mendelev N and Li PA:
Selenium preserves mitochondrial function, stimulates mitochondrial
biogenesis, and reduces infarct volume after focal cerebral
ischemia. BMC Neurosc. 13(79)2012. View Article : Google Scholar
|
|
28
|
Treska V, Kuntscher V, Hasman D, Neprasová
P, Kobr J, Racek J, Trefil L and Hes O: Importance of selenium for
the influence of ischemia–reperfusion syndrome after kidney
transplantation from a non–heart beating donor in a pig model.
Transplant Proc. 34:3057–3059. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin TT, Wang BM, Li XY, Pan Y, Wang W, Mu
Y, Liu JQ, Shen JC and Luo GM: An insight into the protection of
rat liver against ischemia/reperfusion injury by 2–selenium–bridged
beta–cyclodextrin. Hepatol Res. 39:1125–1136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ostadalova I, Vobecky M, Chvojkova Z,
Mikova D, Hampl V, Wilhelm J and Ostadal B: Selenium protects the
immature rat heart against ischemia/reperfusion injury. Mol Cell
Biochem. 300:259–267. 2007. View Article : Google Scholar
|
|
31
|
Zheng QS and Sun RY: Quantitative design
of drug compatibility by weighted modification method. Zhongguo Yao
Li Xue Bao. 20:1043–1051. 1999.
|
|
32
|
Shih YC, Lee PY, Cheng H, Tsai CH, Ma H
and Tarng DC: Adipose derived stem cells exhibit antioxidative and
anti–apoptotic properties to rescue ischemic acute kidney injury in
rats. Plast Reconstr Surg. 132:940e–951e. 2013. View Article : Google Scholar
|
|
33
|
Wang HB, Li YX, Hao YJ, Wang TF, Lei Z, Wu
Y, Zhao QP, Ang H, Ma L and Liu J: et al: Neuroprotective effects
of LBP on brain ischemic reperfusion neurodegeneration. Eur Rev Med
Pharmacol Sci. 17:2760–2765. 2013.PubMed/NCBI
|
|
34
|
Kim J, Jang HS and Park KM: Reactive
oxygen species generated by renal ischemia and reperfusion trigger
protection against subsequent renal ischemia and reperfusion injury
in mice. Am J Physiol Renal Physiol. 298:F158–F166. 2010.
View Article : Google Scholar
|
|
35
|
Guo C, Tong L, Xi M, Yang H, Dong H and
Wen A: Neuroprotective effect of calycosin on cerebral ischemia and
reperfusion injury in rats. J Ethnopharmacol. 144:768–774. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hussein A, Shokeir AA, Sarhan ME,
El–Menabawy FR, Abd Elmoneim HA, El–Nashar EM and Barakat NM:
Effects of combined erythropoietin and epidermal growth factor on
renal ischaemia/reperfusion injury: A randomized experimental
controlled study. BJU Int. 107:323–328. 2011. View Article : Google Scholar
|
|
37
|
Luo YH, Li ZD, Liu LX and Dong GH:
Pretreatment with erythropoietin reduces hepatic
ischemia/reperfusion injury. Hepatobiliary Pancreat Dis Int.
8:294–299. 2009.PubMed/NCBI
|
|
38
|
Yang FL, Subeq YM, Chiu YH, Lee RP, Lee CJ
and Hsu BG: Recombinant human erythropoietin reduces
rhabdomyolysis–induced acute renal failure in rats. Injury.
43:367–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu N, Tian J, Wang W, Cheng J, Hu D and
Zhang J: Effect and mechanism of erythropoietin on mesenchymal stem
cell proliferation in vitro under the acute kidney injury
microenvironment. Exp Biol Med (Maywood). 236:1093–1099. 2011.
View Article : Google Scholar
|
|
40
|
Bozkurt S, Arikan DC, Kurutas EB, Sayar H,
Okumus M, Coskun A and Bakan V: Selenium has a protective effect on
ischemia/reperfusion injury in a rat ovary model: Biochemical and
histopathologic evaluation. J Pediatr Surg. 47:1735–1741. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brines M and Cerami A: Emerging biological
roles for erythropoietin in the nervous system. Nat Rev Neurosci.
6:484–494. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lei DM, Piao SG, Jin YS, Jin H, Cui ZH,
Jin HF, Jin JZ, Zheng HL, Li JJ, Jiang YJ, Yang CW and Li C:
Expression of erythropoietin and its receptor in kidneys from
normal and cyclosporine–treated rats. Transplant Proc. 46:521–528.
2014. View Article : Google Scholar
|
|
43
|
Yang XF, He Y, Li HY, Liu X, Chen H, Liu
JB, Ji WJ, Wang B and Chen LN: Hepatoprotective effects of
erythropoietin on D galactosamine/lipopolysaccharide–induced
fulminant hepatic failure in mice. Mol Med Rep. 10:555–559.
2014.PubMed/NCBI
|
|
44
|
Sanchis–Gomar F, Garcia–Gimenez JL, Pareja
Galeano H, Romagnoli M, Perez–Quilis C and Lippi G: Erythropoietin
and the heart: physiological effects and the therapeutic
perspective. Int J Cardiol. 171:116–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rusai K, Prókai A, Szebeni B, Fekete A,
Treszl A, Vannay A, Müller V, Reusz G, Heemann U, Lutz J, et al:
Role of serum and glucocorticoid–regulated kinase–1 in the
protective effects of erythropoietin during renal
ischemia/reperfusion injury. Biochem Pharmacol. 79:1173–1181. 2010.
View Article : Google Scholar
|
|
46
|
Yang C, Zhao T, Lin M, Zhao Z, Hu L, Jia
Y, Xue Y, Xu M, Tang Q, Yang B, et al: Helix B surface peptide
administered after insult of ischemia reperfusion improved renal
function, structure and apoptosis through beta common
receptor/erythropoietin receptor and PI3K/Akt pathway in a murine
model. Exp Biol Med (Maywood). 238:111–119. 2013. View Article : Google Scholar
|
|
47
|
Xu X, Cao Z, Cao B, Li J, Guo L, Que L, Ha
T, Chen Q, Li C and Li Y: Carbamylated erythropoietin protects the
myocardium from acute ischemia/reperfusion injury through a
PI3K/Akt–dependent mechanism. Surgery. 146:506–514. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Q, Zhang QG, Wu DN, Yin XH and Zhang
GY: Neuroprotection of selenite against ischemic brain injury
through negatively regulating early activation of ASK1/JNK cascade
via activation of PI3K/AKT pathway. Acta Pharmacol Sin. 28:19–27.
2007. View Article : Google Scholar
|
|
49
|
Yoon SO, Kim MM, Park SJ, Kim D, Chung J
and Chung AS: Selenite suppresses hydrogen peroxide induced cell
apoptosis through inhibition of ASK1/JNK and activation of
PI3–K/Akt pathways. FASEB J. 16:111–113. 2002.
|
|
50
|
Mastromarino V, Volpe M, Musumeci MB,
Autore C and Conti E: Erythropoietin and the heart: Facts and
perspectives. Clin Sci (Lond). 120:51–63. 2011. View Article : Google Scholar
|
|
51
|
Gliemann L, Nyberg M and Hellsten Y:
Nitric oxide and reactive oxygen species in limb vascular function:
What is the effect of physical activity? Free Radic Res. 8:71–83.
2014. View Article : Google Scholar
|
|
52
|
Dziodzio T, Biebl M and Pratschke J:
Impact of brain death on ischemia/reperfusion injury in liver
transplantation. Curr Opin Organ Transplant. 19:108–114. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang W, Han Y, Meng G, Bai W, Xie L, Lu
H, Shao Y, Wei L, Pan S, Zhou S, et al: Direct Renin inhibition
with aliskiren protects against myocardial ischemia/reperfusion
injury by activating nitric oxide synthase signaling in
spontaneously hypertensive rats. J Am Heart Assoc. 3:e0006062014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Teng R, Calvert JW, Sibmooh N, Piknova B,
Suzuki N, Sun J, Martinez K, Yamamoto M, Schechter AN, Lefer DJ and
Noguchi CT: Acute erythropoietin cardioprotection is mediated by
endothelial response. Basic Res Cardiol. 106:343–354. 2011.
View Article : Google Scholar : PubMed/NCBI
|
